Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jul 21, 2008
- Comment period
- Jul 21, 2008 – ?
- Agency
- Food and Drug Administration (FDA)
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type, organic comments only.
Comments over time
Weekly arrivals, stacked by stance, organic only.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Feb 4, 2008Comment from American Society of Clinical OncologySupportAdvocacy📎 Attachment
The American Society of Clinical Oncology (ASCO) supports the FDA's Science and Technology Report and its mission to enhance scientific competency. They advocate for increased collaboration with professional societies and other federal agencies like the NIH to leverage existing expertise and ensure consistent scientific standards.
Read comment → - Feb 4, 2008Comment from Various Arkansas StakeholdersSupportAdvocacy📎 Attachment
A coalition of Arkansas-based stakeholders, including state agencies, academic institutions, and private industry leaders, supports the FDA's Science and Technology Report while advocating for the preservation and expansion of the National Center for Toxicological Research (NCTR). They argue that the NCTR is a vital research hub with unique capabilities that should be leveraged to strengthen the FDA's mission, rather than being diminished by geographic distance or organizational weaknesses.
Read comment →